Macrophage contribution to the response of the rat organ of Corti to amikacin.
Transdifferentiation of nonsensory supporting cells into sensory hair cells occurs naturally in the damaged avian inner ear. Such transdifferentiation was achieved experimentally in the cochlea of deaf guinea pigs through Atoh 1 gene transfection. Supporting cells may therefore serve as targets for transdifferentiation therapy. Supporting cells rapidly degenerate after hair cell disappearance, however, limiting the therapeutic window for gene transfer. We studied the time course of ultrastructural and phenotypical changes occurring in Deiters cells (hair cell supporting cells) after ototoxic treatment in the rat. The presence of macrophages in the cochlea was also investigated, to study any deleterious effects they may have on pathologic tissues. One week after treatment most hair cells had disappeared. Deiters cells no longer expressed the glial marker vimentin but instead displayed typical hair cell markers, the calcium binding proteins calbindin and parvalbumin. This suggests that a process of transdifferentiation of Deiters cells into hair cells was activated. By 3 weeks post-treatment, however, the Deiters cells began to degenerate and by 10 weeks post-treatment the organ of Corti was degraded fully. Interestingly, a marked increase in macrophage density was seen after the end of amikacin treatment to 10 weeks post-treatment. This suggests chronic inflammation is involved in epithelium degeneration. Consequently, early treatments with anti-inflammatory factors might promote supporting cell survival, thus improving the efficacy of more specific strategies aimed to regenerate hair cells from nonsensory cells.
Ladrech
Sabine
S
INSERM, U.583, Laboratoire de Physiopathologie et Thérapie des Déficits Sensoriels et Moteurs, Montpellier, France.
Wang
Jing
J
Simonneau
Lionel
L
Puel
Jean-Luc
JL
Lenoir
Marc
M
D000583:Amikacin / Q000633:toxicity*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D015153:Blotting, Western; D064026:Calbindins; D002454:Cell Differentiation / Q000502:physiology; D006198:Hair Cells, Auditory / Q000502:physiology; D007150:Immunohistochemistry; D008264:Macrophages / Q000502:physiology*; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D009410:Nerve Degeneration; D009925:Organ of Corti / Q000187:drug effects* / Q000473:pathology; D010320:Parvalbumins / Q000378:metabolism; D010641:Phenotype; D051381:Rats; D017208:Rats, Wistar; D064030:S100 Calcium Binding Protein G / Q000378:metabolism; D016707:Tissue Fixation; D014746:Vimentin / Q000096:biosynthesis / Q000235:genetics
D000900:Anti-Bacterial Agents; D064026:Calbindins; D010320:Parvalbumins; D064030:S100 Calcium Binding Protein G; D014746:Vimentin; D000583:Amikacin